You are here

Mark Brager
October 14, 2014

Cell Habitats Wins Virginia Rybski MedTech Entrepreneur Award at AdvaMed 2014

CHICAGO, IL. – AdvaMed’s Emerging Growth Company Council (EGCC) announced that Cell Habitats, a Woodridge, Illinois-based tissue repair company, has been awarded the Virginia Shimer Rybski Memorial Award, which recognizes the potential of a promising entrepreneur or entrepreneurial medical technology company.

Cell Habitats, Inc., is working to redefine the field of tissue repair by using biological and physical cues to prompt the body's own stem cells to restore normal function to damaged or diseased tissue. The company’s novel approach involves the injection of “Regenerods,” – micro-sized devices that mimic biological material, attract the body's own stem cells, and act as a substitute cellular habitat that promotes endogenous stem cell growth. This innovation could potentially improve outcomes in the treatment of heart muscle disease, and also serves as a platform for the repair of bone, cartilage, muscle and nerve tissues

“It is an honor to receive the AdvaMed 2014 Virginia Shimer Rybski Memorial Award. I am extremely grateful to the AdvaMed organization for this recognition, as it is a testament to our team’s hard work and ingenuity in advancing our technology,” said Cell Habitats CEO Michael T. Flavin, Ph.D., accepting the award during AdvaMed 2014: The MedTech Conference. “We are thrilled that this award will increase awareness of our company and allow us to continue to advance our development program.”

The Virginia Shimer Rybski Memorial Award was created to encourage the enthusiastic pursuit of business excellence in the medical technology industry. It is named after the late entrepreneur and patient care advocate Virginia Rybski, president and CEO of Regenesis Biomedical and a member of AdvaMed’s Board of Directors and the Association’s EGCC Executive Committee, who passed away in 2013.

The award is presented each year during the Association’s annual meeting to a single presenting company or entrepreneur. This year’s award includes:

  • A $10,000 grant to be applied towards expenses required for commercializing an innovative medical technology;
  • Complimentary membership in AdvaMed for two years; and
  • A complimentary full-access pass to AdvaMed 2015 in San Diego, California, October 5-7, 2015.


AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit

About AdvaMed EGCC

The Emerging Growth Company Council (EGCC) is the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical device and diagnostics manufacturers – the lifeblood of the medical technology industry. The only organization of its kind focusing specifically on the needs of the medtech industry’s emerging growth companies, AdvaMed EGCC works to create a policy environment more conducive to capital formation and innovation. For more information, visit